How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Chapel Hill trades parking for HQ on Franklin St. © 2026 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site ...
Showcase your company news with guaranteed exposure both in print and online For 28 years Triangle Business Journal has been saluting outstanding women leaders in the Triangle… 2nd annual event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results